Updates matching "Access to Biomarker Testing"

ALBANY , NY – DECEMBER 12, 2022 – The American Cancer Society Cancer Action Network (ACS CAN) and Santa Clause join children throughout New York in preparing a Christmas wish list, to be delivered tomorrow by Old Saint Nick to legislators in Albany. WHEN : Santa Clause and

The following was originally published in the Empire Report on December 6, 2022. With over 118,000 New Yorkers forced to hear the dreaded three words “you have cancer” every year, it’s easy to forget the incredible strides in early detection and treatment we’ve made in the last 20

The California Assembly Health Committee passed a bill today that would ensure comprehensive biomarker testing is covered by more insurance plans, including Medi-Cal, when supported by medical and scientific evidence.

Today, the Rhode Island Senate passed legislation that would ensure biomarker testing is covered by more insurance plans, including Medicaid, when patients need it.

WICHITA FALLS, TX – May 6, 2022 – Family and friends recall former Wichita Falls resident Jackie Bush as the definition of bravery, strength and a force to be reckoned with. She undoubtedly left her mark in Texas, and on the hearts of fellow volunteers and legislatures as a lead

The California Senate Health Committee voted to advance a bill that would increase access to biomarker testing, a critical step in accessing precision medicine treatments that can lead to fewer side effects, improved survival, better quality of life and potentially lower costs for cancer patients.

State Senator Monique Limón introduced Senate Bill 912 to increase access to biomarker testing, which can help determine the best treatment plan for a specific patient. ACS CAN and the University of California have teamed up to sponsor this important step in ensuring cancer patients have access to precision medicine.

Statement from American Cancer Society Cancer Action Network (ACS CAN) Government Relations Director Kimberly Hughes Baton Rouge, LA –“The Louisiana legislature recently passed legislation that will improve access to care for cancer patients through co-pay accumulator legislation and the expansion of coverage for biomarker testing. “Many cancer patients have